|
1
|
Kajiyama Y and Tsurumaru M: Esophagectomy
with lymph node dissection through right thoracotomy. Nihon Geka
Gakkai Zasshi. 103:343–347. 2002.(In Japanese).
|
|
2
|
Akiyama H, Tsurumaru M, Udagawa H and
Kajiyama Y: Radical lymph node dissection for cancer of the
thoracic esophagus. Ann Surg. 220:364–373. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kajiyama Y, Iwanuma Y, Tomita N, et al:
Indication and limitation of 3-field lymph node dissection surgery
for esophageal cancer from survival analysis. J Jpn Surg Assoc.
68:795–804. 2007. View Article : Google Scholar
|
|
4
|
Kajiyama Y, Iwanuma Y, Tomita N, et al:
Current surgical treatment for esophageal cancer: Indication and
limitation of 3-field lymph node dissection surgery based on
survival analysis. Juntendo Med J. 53:542–551. 2007.(In
Japanese).
|
|
5
|
Guide line for the clinical and pathologic
studies on carcinoma of the esophagus. 9th edition. Japan
Esophageal Society. 8:23. 1999.
|
|
6
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumours. 7th edition.
International Union Against Cancer (UICC). Wiley-Blackwell; West
Sussex: 2009
|
|
7
|
Japanese translation of common terminology
criteria for adverse events (CTCAE) version 4.0. JCOG; 2009
|
|
8
|
Kajiyama Y and Tsurumaru M: Preservation
of right and left bronchial arteries. Gastroentrological Surg.
30:151–157. 2007.
|
|
9
|
Kajiyama Y and Tsurumaru M: Treatment of
esophageal cancer: open vs. thoracoscopic surgery. Nihon Geka
Gakkai Zasshi. 106:357–360. 2005.(In Japanese).
|
|
10
|
Kajiyama Y, Iwanuma Y, Tomita N, et al:
Lymph node dissection along the recurrent laryngeal nerve and
preservation of bronchial artery in esophageal cancer surgery.
Gastroentrological Surg. 34:1–9. 2011.
|
|
11
|
Tsurumaru M, Kajiyama Y, Iwanuma Y, et al:
Surgical and anatomical problems of the vagus nerve (recurrent
laryngeal nerve) in patients with cancer of the thoracic esophagus:
View of open surgery. In: 8th Japanese Research Society of Clinical
Anatomy Meeting; 5. 2005
|
|
12
|
Kajiyama Y, Iwanuma Y, Tomita N, et al:
Progress and perspective of trans-thoracic esophageal cancer
surgery. Gastroentrological Surg. 35:1079–1085. 2012.
|
|
13
|
Kajiyama Y, Tsurumaru M, Iwanuma Y, et al:
Controversies in esophageal cancer surgery. Jpn J Cancer Chemother.
30:1225–1229. 2003.(In Japanese).
|
|
14
|
Matsubara H: New strategy for esophageal
cancer. Chiba Igaku Zasshi. 84:69–74. 2008.(In Japanese).
|
|
15
|
Ando N, Iizuka T, Ide H, et al: Surgery
plus chemotherapy compared with surgery alone for localized
squamous cell carcinoma of the thoracic esophagus: A Japan Clinical
Oncology group study - JCOG 9204. J Clin Oncol. 21:4592–4596. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guide line on diagnosis and treatment for
esophageal cancer. 2th edition. Japan Esophageal Society; 2007
|
|
17
|
Ajani JA, Ryan B, Rich TA, McMurtey M,
Roth JA, DeCaro L, Levin B and Mountain C: Prolonged chemothrerapy
for localized squamous carcinoma of the oesophagus. Eur J Cancer.
28A. pp. 880–884. 1992, View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hilgenberg AD, Carey RW, Wilkins EW Jr,
Choi NC, Mathisen DJ and Grillo HC: Preoperative chemotherapy,
surgical resection, and selective postoperative therapy for
squamous cell carcinoma of the esophagus. Ann Thorac Surg.
45:357–363. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kelsen D: Chemothrapy of esophageal
cancer. Semin Oncol. 11:159–168. 1984.PubMed/NCBI
|
|
20
|
Iizuka T, Kakegawa T, Ide H, et al: Phase
II evaluation of cisplatin and 5-fluorouracil in advanced squamous
cell carcinoma of the esophagus:a Japanese Esophageal Oncology
Group Trial. Jpn J Clin Oncol. 22:172–176. 1992.PubMed/NCBI
|
|
21
|
Kok TC, Van der Gaast A, Dees J, Eykenboom
WM, Van Overhagen H, Stoter G, Tilanus HW and Splinter TA:
Cisplatin and etoposide in oesophageal cancer: a phase II study.
Rotterdam Oesophageal Tumour Study Group. Br J Cancer. 74:980–984.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ilson DH, Saltz L, Enzinger P, Huang Y,
Kornblith A, Gollub M, ‘Reilly E, Schwartz G, DeGroff J, Gonzalez G
and Kelsen DP: Phase II trial of weekly irinotecan plus cisplatin
in advanced esophageal cancer. J Clin Oncol. 17:3270–3275.
1999.PubMed/NCBI
|
|
23
|
Ilson DH, Ajani J, Bhalla K, Forastiere A,
Huang Y, Patel P, Martin L, Donegan J, Pazdur R, Reed C and Kelsen
DP: Phase II trial of paclitaxel, fluorouracil, and cisplatin in
patients with advanced carcinoma of the esophagus. J Clin Oncol.
16:1826–1834. 1998.PubMed/NCBI
|
|
24
|
Kroep JR, Pinedo HM, Giaccone G, Van
Bochove A, Peters GJ and Van Groeningen CJ: Phase II study of
cisplatin preceding gemcitabine in patients with advanced
oesophaeal cancer. Ann Oncol. 15:230–235. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Millar J, Scullin P, Morrison A, McClory
B, Wall L, Cameron D, Philips H, Price A, Dunlop D and Eatok M:
Phase II study of gemcitabine and cisplatin in locally
advanced/metastatic oesophageal cancer. Br J Cancer. 93:1112–1116.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mauer AM, Kraut EH, Krauss SA, Ansari RH,
Kasza K, Szeto L and Vokes EE: Phase II trial of oxaliplatin,
leucovorin and fluorouracil in patients with advanced carcinoma of
the esophagus. Ann Oncol. 16:1320–1325. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van Meerten E, Eskens FA, van Gameren EC,
Doorn L and van der Gaast A: First-line treatment with oxaliplatin
and capecitabine in patients with advanced or metastatic
oesophageal cancer: a phase II study. Br J Cancer. 96:1348–1352.
2007.PubMed/NCBI
|
|
28
|
Tsuda T and Boku N: Current realities and
problems of chemotherapy for esophageal cancer. Gastroentrological
Surg. 35:1117–1122. 2012.
|
|
29
|
Van Cutsem E, Moiseyenko VM, Tjulandin S,
et al; V325 Study Group. Phase III study of docetaxel and cisplatin
plus fluorouracil compared with cisplatin and fluorouracil as
first-line therapy for advanced gastric cancer: a report of the
V325 Study Group. J Clin Oncol. 24:4991–4997. 2006.PubMed/NCBI
|
|
30
|
Posner MR, Hershock DM, Blajman CR, et al:
Cisplatin and fluorouracil alone or with docetaxel in head and neck
cancer. N Engl J Med. 357:1705–1715. 2007. View Article : Google Scholar : PubMed/NCBI
|
